Isoprostane 8-epi-PGF2α is frequently increased in patients with muscle pain and/or CK-elevation after HMG-Co-enzyme-A-reductase inhibitor therapy

Journal of Clinical Pharmacy and Therapeutics

Volumn 26, Issue 4, 2001, Pages 303-310

  Sinzinger, H ^a,b,e   Lupattelli, G ^c   Chehne, F ^a   Oguogho, A ^a   Furberg, C D ^d  

^a UNIVERSITY OF VIENNA   (Austria)

^b Institute for Diagnosis and Treatment of Lipid Disorders and Atherosclerosis (ATHOS)   (Austria)

^c UNIVERSITY OF PERUGIA   (Italy)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e Institute for Diagnosis and Treatment of Lipid Disorders and Atherosclerosis (ATHOS)   (Austria)

Author keywords

8 epi PGF2; Creatinine phospho kinase (CK); HMG co enzyme A reductase inhibitor; Hyperlipoproteinemia; Isoprostanes; Muscle pains; Oxidation injury

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; CREATINE KINASE; CREATINE KINASE MB; FLUINDOSTATIN; GAMMA GLUTAMYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DRUG EFFECT; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; MALE; MYALGIA; OXIDATIVE STRESS; SMOKING; SYMPTOM; URINALYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; CREATINE KINASE; DINOPROST; F2-ISOPROSTANES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIAS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; PAIN; VASOCONSTRICTOR AGENTS;

EID: 0035722158     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2001.00360.x     Document Type: Article

References (17)

1. 2α in familial hypercholesterolemia: Evidence of oxidative stress in vivo
2. Isoprostanes in atherosclerotic lesions
3. Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment
4. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin and simvastatin, using neonatal rat skeletal myocytes
5. Does vitamin E beneficially affect muscle pains during HMG-Co-enzyme-A-reductase inhibitors without CK-elevation?
6. Increased lipid peroxidation in patients with rhabdomyolysis
7. Richtlinien des cholesterin-konsens 1995
8. 2α, is formed in-vivo
9. The isoprostanes: Current knowledge and direction of future research
10. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease
11. Modulation of oxidant stress in-vivo in chronic cigarette smokers
12. 2α is increased in hypercholesterolemia
13. 2α in heterozygous hypercholesterolemia
14. Isoprostanes quickly normalize after quitting cigarette smoking in healthy adults
15. Synergistic renal protection by combining alkaline-diuresis with lipid peroxidation inhibitors in rhabdomyolysis: Possible interaction between oxidant and non-oxidant mechanisms
16. Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans
17. The effect of simvastatin treatment on matural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle